Showing results (151-160 of 410) with videos related to

Sort By:
Pageof 41
The British Journal of Cancer. Supplement|August 1, 1992
Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study GroupJ Vormoor, J Ritter, U Creutzig, et al.
Pediatric Blood & Cancer|December 17, 2005
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AMLG J L Kaspers, D Reinhardt, G Fleischhack, et al.
Studies in Health Technology and Informatics|February 24, 2001
Requirements and design aspects of a data model for a data dictionary in paediatric oncologyA Merzweiler, P Knaup, U Creutzig, et al.
Leukemia|June 11, 2010
Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trialsA Sander, M Zimmermann, M Dworzak, et al.
Annals of Hematology|March 1, 1995
Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaE Weidmann, J Brieger, B Jahn, et al.
Leukemia|December 1, 1994
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cellsJ Brieger, E Weidmann, K Fenchel, et al.
Klinische Padiatrie|August 8, 2002
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study]D Reinhardt, C Langebrake, U Creutzig, et al.
Klinische Padiatrie|July 1, 1992
[Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group]U Creutzig, J Ritter, P Heyen, et al.
Leukemia|November 1, 1996
Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study GroupU Creutzig, J Ritter, J Vormoor, et al.
Klinische Padiatrie|July 1, 1990
[Transient myeloproliferation and acute myeloid leukemia in infants with Down's syndrome]U Creutzig, J Ritter, J Vormoor, et al.
Pageof 41